Locations:
Search IconSearch

Research

mukherjee_650x450
December 10, 2017/Cancer/Research

Predictors of 30-day Unplanned Readmissions in Patients with Hematologic Malignancies

Disease-related, clinical and discharge-associated factors

hamilton_650x450
December 10, 2017/Cancer/Research

The Cost of Chronic Graft Versus Host Disease

A cross-sectional survey from the Chronic GVHD Consortium

Dr.-Hill_650x450
December 10, 2017/Cancer/Research

Autologous Hematopoietic Cell Transplant Improves Survival in Mantle Cell Lymphoma

Multicenter study shows survival benefit for patients ≤ 65

red-blood-cells_650x450
December 9, 2017/Cancer/Research

In Myelofibrosis, New Possibilities for Minimizing Symptoms and Drug Side Effects

JAK inhibitors, the hedgehog pathway and answers for anemia

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Khorana_650x450
December 9, 2017/Cancer/Research

Cancer Patients with VTE Treated in ED Face Higher Mortality Risks

Prevention, early detection best strategy

Pederson_650x450
December 5, 2017/Cancer/Research

The Impact of Multigene Panel Testing on Surgical Decisions for Breast Cancer Patients

Finding variants of uncertain significance does not increase the rate of contralateral prophylactic mastectomies

yogen_650x450
November 20, 2017/Cancer/Research

New Sickle Cell Disease Treatment Shows Positive Results in Phase 1 Clinical Trial

Novel drug could greatly improve patient outcomes

BackPage 26 of 31Next

Advertisement

Ad